Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hookipa Pharma Inc

1.34
-0.0500-3.60%
Pre-market: 1.340.00000.00%08:00 EST
Volume:22.44K
Turnover:31.37K
Market Cap:13.27M
PE:-0.38
High:1.46
Open:1.38
Low:1.34
Close:1.39
Loading ...

Hookipa Pharma (HOOK) Receives a Hold from RBC Capital

TIPRANKS
·
04 Mar

BRIEF-Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger

Reuters
·
21 Feb

Poolbeg Pharma Plc - HOOKIPA Has Terminated Discussions on Proposed Combination of Two Companies

THOMSON REUTERS
·
21 Feb

Hookipa Pharma announces enrollment completion of Phase 1b HB-500 trial

TIPRANKS
·
30 Jan

HOOKIPA Pharma Inc - Primary Completion of Phase 1B Trial Expected H2 2025

THOMSON REUTERS
·
30 Jan

HOOKIPA Pharma Inc - Phase 1B Trial Evaluating Safety and Immunogenicity of Hb-500

THOMSON REUTERS
·
30 Jan

HOOKIPA Pharma Announces Enrollment Completion of Phase 1B Clinical Trial Evaluating Hb-500 for the Treatment of Hiv

THOMSON REUTERS
·
30 Jan

HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV

GlobeNewswire
·
30 Jan

Poolbeg Agrees to Bid Deadline Extension for Possible Hookipa Pharma Deal

Dow Jones
·
30 Jan

Hookipa Pharma (HOOK) was downgraded to a Hold Rating at Citi

TIPRANKS
·
12 Jan

HC Wainwright Downgrades HOOKIPA Pharma to Neutral From Buy

MT Newswires Live
·
10 Jan

HOOKIPA Pharma Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
10 Jan

Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA

GlobeNewswire
·
10 Jan

HOOKIPA Pharma Announces Notice to Shareholders Regarding U.k. Disclosure Requirements

THOMSON REUTERS
·
08 Jan

HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements

GlobeNewswire
·
08 Jan

Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA

GlobeNewswire
·
07 Jan